Rapid Expansion of Ambulatory and Remote Patient Care Infrastructure, Strengthening of Healthcare Expertise, Constant Advancements in Ultrasound Technology, And Increase in Public and Private Sector Spending On Healthcare Infrastructure Are Factors Supporting Market Growth
United States, Rockville MD, Aug. 11, 2022 (GLOBE NEWSWIRE) -- As per a detailed survey by Fact.MR, a market research and competitive intelligence provider, worldwide demand for portable ultrasound equipment is projected to rise at a CAGR of 6.8% from 2022 to 2026.
Portable ultrasound devices use ultrasound technology and have a portable benefit over larger ultrasound devices used in hospitals. Portable ultrasound technology has applications in many areas, including emergency medicine, critical care medicine, and musculoskeletal health.
Rise in the prevalence of several illnesses, increasing trauma and accident cases, surge in the demand for less intrusive procedures, and a senior population at high risk of disease are the main factors driving the global market for portable ultrasound equipment. The market is growing because of technological innovations in the fields of emergency medicine and primary care, and the rising demand for portable ultrasonography.
For Critical Insights on Portable Ultrasound Equipment Market, Request a Sample Report https://www.factmr.com/connectus/sample?flag=S&rep_id=7608
The global market is also expected to be driven by aspects such as lower cost than traditional scanners, wireless systems, potable, automated, privacy-preserving, high-quality transducers, shorter diagnostic times, and efficient point-of-care and remote diagnosis applications.
Market growth is also attributed to the rising impact of the increased disease burden around the world, increasing cooperative initiatives by government organizations for the prevention and control of maternal and infant mortality, and increased awareness programs about the advantages of portable ultrasound equipment.
How is Portable Ultrasound Equipment Market Expansion Being Driven?
“Ever-growing Demand for Effective Medical Equipment & Non-invasive Diagnostic Solutions”
The demand for effective medical equipment is rising as the prevalence of serious illnesses and disorders rises. Portable ultrasound machines are advantageous in this regard for individuals with mobility problems, such as obese or paraplegic patients.
Demand for non-invasive diagnostic solutions is also increasing, this is anticipated to fuel the market growth during the anticipated period.
Additionally, it is anticipated that rising consumer spending on routine health screenings will support industry expansion. The rising use of advanced technology such as artificial intelligence (AI) in these imaging systems is one of the most important developments now being seen in the global market.
Additionally, ultrasound-based quantification is being established using these innovative technologies. Deep learning techniques are being utilized to integrate measurements using software for ultrasound-based imaging analysis. Because of the wide range of medical applications linked to the system, more and more medical practitioners are adopting these gadgets.
To learn more about Portable Ultrasound Equipment Market, you can get in touch with our Analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=7608
Key Segments Covered in the Portable Ultrasound Equipment Industry Survey
Leading market players engaged in R&D projects to deliver technologically advanced products. To increase their client base and market share, key companies are attempting to upgrade their products, utilizing significant cooperative efforts, exploring acquisitions, and obtaining government permissions.
In 2020, Clarius Mobile Health stated that pain management specialists all around the world are increasingly using its Clarius L7 HD handheld ultrasound scanner. For a more dependable and accurate application of painkillers, ultrasound imaging of the anatomy beneath the skin tends to be of higher quality.
Get Customization on Portable Ultrasound Equipment Market Report for Specific Research Solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=7608
Key players in the Portable Ultrasound Equipment Market
Key Takeaways from Portable Ultrasound Equipment Market Study
The global portable ultrasound equipment market is currently valued at US$ 2 billion.
Market in Japan anticipated to increase at 5.5% CAGR over forecast period.
Demand for handheld portable ultrasound equipment anticipated to rise at 5% CAGR from 2022 to 2026.
Market in Canada projected to increase at 5.8% CAGR through 2026.
Explore Fact.MR's Coverage on the Healthcare Domain-
Antimicrobial Susceptibility Test Market - Antimicrobial Susceptibility Test Market Analysis Repot By Product (Kits, Reagents, & Consumables, Automated Test Systems, Culture Media), By Application (Clinical Diagnosis, Drug Discovery and Development), By End User, By Region - Global Insights 2020-2025
Antacids Market - Antacids Market Analysis Report By Drug Class (Proton Pump Inhibitors, H2 Antagonists), By Distribution Channel (Hospital, Retain Pharmacies), By Formulation, By Region - Global Market Insights 2020-2025
Anticoagulant Reversal Drugs Market - Anticoagulant Reversal Drugs Market Analysis Repot By Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, Andexxa), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region - Global Insights 2020-2026
Anticancer Drugs Market - Anticancer Drugs Market Analysis Repot By Drug Type (Targeted Drugs, Cytotoxic Drugs, Hormonal Drugs), By Cancer Type (Lung Cancer, Breast Cancer, Leukemia, Colorectal Cancer), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy) - Global Market Forecast 2020-2025
Apheresis Market - Apheresis Market Analysis Repot By Technology (Centrifugation, Membrane Filtration), By Product (Devices, Disposables), By Application (Renal Diseases, Neurology, Haematology, Cancer, Autoimmune Diseases,Cardiovascular Diseases), By Region - Global Market Forecast 2020-2025
Aptamers Market - Aptamers Market Analysis Repot By Application (Research, Diagnostics, Therapeutics), By Selection Technique (SELEX Technique), By Material (Nucleic Acid Aptamers, Peptide Aptamers), By Region - Global Market Forecast to 2010-2025
Dental 3D Printing Market - Dental 3D Printing Market Size, Trend Analysis & Competition Tracking By Material (Metals, Photopolymers, Ceramics), By Application (Dental Implants, Dentures, Crowns & Bridges), By Technology (Vat Photo Polymerization, Fused Deposition Modelling, PolyJet Technology, Selective Laser Sintering) - Global Market Insights 2021 to 2031
Behavioural Health Treatment Market - Behavioural Health Treatment Market Analysis Report By Disorder (Depression, Anxiety, Schizophrenia, Bipolar Disorder, Alcohol Use Disorders, Substance Use Disorders, Eating Disorders, Post-traumatic Stress Disorders), By Service, By Region -Global Forecast 2020-2027
Assisted Reproductive Technology Market - Assisted Reproductive Technology Market Analysis Report By Procedure (Frozen Donor, Frozen Non-donor, Fresh Donor, Fresh Non-donor, Embryo Banking), By Technology (In-vitro Fertilization, Surrogacy, Artificial Insemination), By End User(Fertility Clinics, Hospitals, Other )- Global Market Insights to 2019-2025
Asthma Treatment Market - Asthma Treatment Market Analysis Report By Treatment Type (Long-term Asthma Control Medications, Quick-relief (Rescue) Medications), By Route of Administration(Inhaled, Oral, Intravenous, Subcutaneous), By Region - Global Forecast 2020 to 2027
About Us: Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact: Mahendra Singh US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 Email: sales@factmr.com Tel: +1 (628) 251-1583 Follow Us: LinkedIn | Twitter
UNITY Biotechnology Inc (NASDAQ: UBX) shares are skyrocketing after 12- and 18-week data from its Phase 2 BEHOLD study of UBX1325 for diabetic macular edema (DME). DME is a diabetic complication that affects the blood vessels in the back of your eye. At 18 weeks after a single UBX1325 injection, the mean change in BCVA of UBX1325-treated subjects was an increase of 6.1 ETDRS letters, representing an improvement of +5.0 ETDRS letters compared to sham-treated subjects. Related: UNITY Biotech Stock
Alibaba Group Holding Limited (NYSE: BABA) and Tencent Holding Ltd (OTC: TCEHY) submitted the algorithm details of some of their products to China's top internet watchdog, Reuters reports. The submission was a part of China's sweeping crackdown on the sector. The internet platforms faced flak for abusing algorithms to invade user privacy and manipulate their choices. The Cyberspace Administration of China (CAC) published a list of 30 algorithms used in some of the country's most popular apps, in
The U.S. Centers For Disease Control and Prevention has relaxed some guidelines around COVID-19, including the quarantine recommendation for people who have been exposed. Officials say the new guidelines are meant to educate people on how to stay safe without causing much disruption to life, school and work.
John Mackey is bowing out in the battle between CEOs and a new generation entering the workforce, but as he told "Reason," he’s not leaving silently.
A new class of drugs developed by Eli Lilly and Novo Nordisk have shown striking results in studies, letting many people safely lose 20% of their weight. If insurers step up to back them, the drugs—and the stocks—could take off.
In this article, we discuss 10 cheap oil stocks to buy today. If you want to skip our detailed analysis of these stocks, go directly to 5 Cheap Oil Stocks to Buy Today. With WTI crude oil prices topping $120 per barrel as recently as mid-June, concerns over rising interest rates and a potential U.S. […]
Kazakhstan is expected to sell some of its crude oil through Azerbaijan's biggest oil pipeline from September, as the nation seeks alternatives to a route Russia threatened to shut, three sources familiar with the matter said. For 20 years, they have been shipped through the CPC pipeline to Russia's Black Sea port of Novorossiisk, which provides access to the global market. In July a Russian court threatened to shut the CPC, prompting the Kazakh government and major foreign producers to set up contracts for other outlets as a precaution.
The pharma giant hit back at allegations that the use of Zantac, known chemically as ranitidine, increases the risk of cancer.
Analysts at Goldman Sachs said commodity markets were behaving irrationally, and warned of "unsustainable prices." Prices and inventories are falling, while demand is beating expectations and supply is disappointing, they said in a note late Thursday. Normally, a combination of higher demand and lower supply would make prices rise. The bank lowered its forecast for Brent prices earlier this week. It now predicts $125 a barrel in three months' time and $120 a barrel in 12 months. Goldman Sachs pr
(Bloomberg) -- Mexico — which imports nearly all of the natural gas it burns — has laid out a somewhat surprising mission: to become one of the world’s top exporters of the fuel, and fast.Most Read from BloombergAuthor Salman Rushdie Attacked on Lecture Stage in New YorkThe Fed’s Damage to the Housing Market May Last YearsStriking Drop in Stress Hormone Predicts Long Covid in StudyTrump Calls for Release of Warrant Documents Used in SearchPutin’s War Sends Russian Economy Back to 2018 in Single
Let's check out a few charts of crude oil prices to see if the rally is resuming. In this daily bar chart of the nearby crude oil futures contract, below, we can see that prices are trying to regain their strength and close back above the rising 200-day moving average line. The daily On-Balance-Volume (OBV) looks like it has been improving in August.
The FTSE 100 pharmaceutical giant's share price suffered its biggest drop since 1998 on Thursday.
Karuna Therapeutics (KRTX) is progressing well with its pipeline development. KRTX's lead candidate meets late-stage study goals as a potential treatment for adults with schizophrenia.
Pfizer (PFE) offers to buy Global Blood Therapeutics (GBT) for $5.4 billion in cash. J&J (JNJ) to discontinue selling talc-based baby powder globally from 2023.
Being publicly traded means you can see how investor sentiment changes by the minute, almost like keeping score in a video game. Kiwi Camara, CEO of legal software company Disco, acknowledges it's human nature to keep an eye on the stock price, but stresses the importance of separating that from long-term strategic planning. Learn more about Disco's first year on the New York Stock Exchange in this ATX Next podcast interview.
U.S. manufacturing would make certain vehicle models eligible for a tax credit under the Inflation Reduction Act, a $430 billion bill focused on lowering healthcare costs, promoting clean energy and increasing corporate taxes. Demand for electric vehicles has surged as countries worldwide chase cleaner transport options and seek to achieve net-zero carbon emissions targets to tackle climate change. Production of the Ocean sports utility vehicle (SUV) is slated to begin this November at contract manufacturer Magna International's Austrian unit.
(Bloomberg) -- Five of China’s largest state-owned companies announced plans to delist from US exchanges as the two countries struggle to come to an agreement allowing American regulators to inspect audits of Chinese businesses.Most Read from BloombergAuthor Salman Rushdie Attacked on Lecture Stage in New YorkTrump Calls for Release of Warrant Documents Used in SearchThe Fed’s Damage to the Housing Market May Last YearsStriking Drop in Stress Hormone Predicts Long Covid in StudyPutin’s War Sends
Five Chinese state-owned companies said they intend to delist their American depositary shares from the New York Stock Exchange, as financial regulators in Beijing and Washington remain at loggerheads over U.S. audit requirements. In separate filings to Hong Kong’s stock exchange Friday, PetroChina , China Petroleum & Chemical , Aluminum Corp. of China , China Life Insurance Co , and Sinopec Shanghai Petrochemical Co said they have notified the NYSE that they plan to voluntarily delist their American depositary shares.
Demand remains strong for automakers, with supply constraints preventing inventory buildup and supporting strong pricing.
Berkshire Hathaway's 13F filings don't tell the full story about the company's holdings.